Paper80576
Aminoglutethimide in treatment of metastatic breast carcinoma.
Smith IE and 8 others. Lancet, 1978. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Aminoglutethimide in treatment of metastatic breast carcinoma. Papers, record 80576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/80576
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoglutethimide | Major topic |
| Bone Neoplasms | Major topic |
| Breast Neoplasms | Major topic |
| Liver Neoplasms | Major topic |
| Lung Neoplasms | Major topic |
| Soft Tissue Neoplasms | Major topic |
| Administration, Oral | |
| Adrenal Cortex Hormones | |
| Aged | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Neoplasm Recurrence, Local |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34198684 | Sex Hormones Related Ocular Dryness in Breast Cancer Women. | J Clin Med | 2021 | https://conductscience.org/library/papers/34198684 | PubMed |
| 29719441 | Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects. | Curr Oncol | 2018 | https://conductscience.org/library/papers/29719441 | PubMed |
| 25032258 | Status of adjuvant endocrine therapy for breast cancer. | Breast Cancer Res | 2014 | https://conductscience.org/library/papers/25032258 | PubMed |
| 18500381 | Indirect androgen doping by oestrogen blockade in sports. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18500381 | PubMed |
| 7348572 | Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment. | Breast Cancer Res Treat | 1981 | https://conductscience.org/library/papers/7348572 | PubMed |
| 7126424 | Polymorphically acetylated aminoglutethimide in humans. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7126424 | PubMed |
| 6797571 | Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6797571 | PubMed |
| 6684948 | Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6684948 | PubMed |
| 6293627 | Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review. | Breast Cancer Res Treat | 1981 | https://conductscience.org/library/papers/6293627 | PubMed |
| 6277358 | Effects of endocrine therapy on steroid-receptor content of breast cancer. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6277358 | PubMed |
| 4015950 | Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients. | Br J Cancer | 1985 | https://conductscience.org/library/papers/4015950 | PubMed |
| 3978028 | Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3978028 | PubMed |
| 2963170 | On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer. | Klin Wochenschr | 1987 | https://conductscience.org/library/papers/2963170 | PubMed |
| 2933050 | A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. | Br J Cancer | 1985 | https://conductscience.org/library/papers/2933050 | PubMed |
| 2322991 | Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2322991 | PubMed |
| 2149401 | Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate. | Med Oncol Tumor Pharmacother | 1990 | https://conductscience.org/library/papers/2149401 | PubMed |
| 2145964 | The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2145964 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/80576
GET https://conductscience.org/api/papers/v1/80576/authors